paeonol has been researched along with arachidonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Hamazaki, T; Hirai, A; Kumagai, A; Saito, H; Sajiki, J; Tahara, K; Tamura, Y; Terano, T | 1 |
2 other study(ies) available for paeonol and arachidonic acid
| Article | Year |
|---|---|
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Studies on the mechanism of antiaggregatory effect of Moutan Cortex.
Topics: Acetophenones; Administration, Oral; Adult; Arachidonic Acid; Arachidonic Acids; Depression, Chemical; Drugs, Chinese Herbal; Humans; In Vitro Techniques; Male; Paeonia; Plant Extracts; Plants, Medicinal; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1983 |